Clinical trial
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
NCT01413061 · AlloSource, Industry · Completed
Key facts
| NCT number | NCT01413061 |
|---|---|
| Title | Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft |
| Official title | Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft |
| Lead sponsor | AlloSource, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Degenerative Osteoarthritis, Post-traumatic, Arthrosis, Rheumatoid Arthritis & Other Inflammatory Polyarthropathies, Rheumatoid Arthritis of Subtalar Joint |
| Intervention type | Procedure |
| Interventions | Subtalar Arthrodesis |
| Enrollment | 140 |
| Start date | Jun 1, 2010 |
| Primary completion | Feb 1, 2017 |
| Completion | Mar 1, 2018 |
| First posted | Aug 10, 2011 |
| Last update posted | Apr 13, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: